Insulet
PODD
#2071
Rank
A$14.04 B
Marketcap
A$202.57
Share price
1.20%
Change (1 day)
-61.00%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2026 (TTM): A$0.69 Billion

According to Insulet's latest financial reports the company's current earnings are A$2.90 Billion. In 2025 the company made an earning of A$0.55 Billion, an increase over its 2024 earnings that were of A$0.47 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.69 B25.44%
2025 A$0.55 B16.3%
2024 A$0.47 B36.76%
2023 A$0.35 B481.9%
2022 A$60.15 M-45.24%
2021 A$0.10 B43.35%
2020 A$76.62 M18.51%
2019 A$64.66 M41.16%
2018 A$45.8 M-711.95%
2017 -A$7.49 Million-56.85%
2016 -A$17.35 Million-79.31%
2015 -A$83.87 Million63.85%
2014 -A$51.19 Million31.04%
2013 -A$39.07 Million-21.96%
2012 -A$50.06 Million
2010 -A$47.74 Million-42.38%
2009 -A$82.86 Million-33.56%
2008 -A$0.13 Billion65.93%
2007 -A$75.16 Million209.75%
2006 -A$24.27 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$36.26 B 5,436.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$11.35 B 1,634.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
A$9.56 B 1,360.14%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
A$43.44 B 6,533.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-A$0.14 Billion-120.90%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
A$0.13 B-79.14%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
A$1.70 B 160.08%๐Ÿ‡บ๐Ÿ‡ธ USA